verywellhealth22d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
The Indian Express25d
A new study says Iron Age began hundreds of years earlier – in Tamil Nadu. Why this is important
In an announcement that challenges long-held assumptions about the origins of the Iron Age, a new study has found evidence that the use of iron in the area that is now Tamil Nadu dates back to the ...
The Hindu26d
Iron Age began in Tamil Nadu in first quarter of 4th millennium BCE: CM Stalin
In a significant finding that alters the understanding of the antiquity of iron in the Indian subcontinent, a report released by Tamil Nadu Chief Minister M.K. Stalin on Thursday said introduction ...
The New Indian Express26d
Iron Age began in Tamil Nadu, declares CM Stalin citing global scientific research
CHENNAI: Chief Minister M K Stalin on Thursday, based on the results of scientific dating of archaeological samples, declared that iron was used in the present Tamil-speaking region even in the ...
Popular Science28d
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
UPI28d
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...